Send me real-time posts from this site at my email
Zacks

Zacks.com featured highlights include: TakeTwo Interactive Software, Gilead Sciences and Regeneron Pharmaceuticals

For Immediate Release

Chicago, IL – May 28, 2020 – Stocks in this week’s article are TakeTwo Interactive Software TTWO, Gilead Sciences GILD and Regeneron Pharmaceuticals REGN.

3 Top-Ranked Stocks with Upgraded Broker Rankings to Buy Now

Given the current volatile market conditions amid coronavirus-related mayhem and economic slowdown, it is very difficult for retail investors to choose stocks on their own. Therefore, advice from experts becomes extremely crucial.

You can just follow broker rating upgrades. Brokers have deeper insight into stocks, sectors and the overall economy. Moreover, they directly communicate with top management, and thoroughly study publicly available documents as well as attend conference calls. At times, they even interact with customers to better understand product demand.

Further, brokers scrutinize the fundamentals of companies and place them against the current economic backdrop to find out how the stocks will fare as an investment option. So, by following broker rating upgrades, you can easily find attractive stocks.

Nevertheless, depending solely on broker upgrades is not a wise thing to do. You must also take into consideration a few other factors before adding a stock to your investment portfolio. In this way, you can ensure solid returns.

For the rest of this Screen of the Week article please visit Zacks.com at:https://www.zacks.com/stock/news/946964/3-topranked-stocks-with-upgraded-broker-ratings-to-buy-now

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter: 

Join us on Facebook:  http://www.facebook.com/ZacksInvestmentResearch">http://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: www.Zacks.com

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.

 

 

 

            


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Regeneron Pharmaceuticals, Inc. (REGN): Free Stock Analysis Report
 
Gilead Sciences, Inc. (GILD): Free Stock Analysis Report
 
TakeTwo Interactive Software, Inc. (TTWO): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue